Tower Research Capital (TRC)’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$407K Buy
26,300
+13,700
+109% +$212K 0.01% 1159
2025
Q1
$187K Sell
12,600
-8,298
-40% -$123K 0.01% 1413
2024
Q4
$277K Buy
20,898
+16,826
+413% +$223K 0.01% 1473
2024
Q3
$57.9K Sell
4,072
-2,421
-37% -$34.4K ﹤0.01% 2643
2024
Q2
$84K Buy
6,493
+5,233
+415% +$67.7K ﹤0.01% 2704
2024
Q1
$17.5K Sell
1,260
-5,490
-81% -$76.3K ﹤0.01% 3117
2023
Q4
$96.3K Buy
6,750
+4,626
+218% +$66K ﹤0.01% 2669
2023
Q3
$32.9K Sell
2,124
-242
-10% -$3.74K ﹤0.01% 2949
2023
Q2
$37.2K Sell
2,366
-470
-17% -$7.38K ﹤0.01% 2811
2023
Q1
$47K Buy
2,836
+527
+23% +$8.73K ﹤0.01% 2555
2022
Q4
$36K Buy
+2,309
New +$36K ﹤0.01% 2594
2022
Q3
Sell
-11,938
Closed -$168K 6476
2022
Q2
$168K Buy
11,938
+8,184
+218% +$115K ﹤0.01% 1906
2022
Q1
$54K Buy
+3,754
New +$54K ﹤0.01% 2671
2021
Q3
Sell
-10,165
Closed -$171K 6158
2021
Q2
$171K Sell
10,165
-13,810
-58% -$232K ﹤0.01% 2035
2021
Q1
$438K Buy
23,975
+23,775
+11,888% +$434K 0.01% 1351
2020
Q4
$4K Sell
200
-450
-69% -$9K ﹤0.01% 4730
2020
Q3
$12K Sell
650
-1,792
-73% -$33.1K ﹤0.01% 4033
2020
Q2
$44K Buy
2,442
+2,427
+16,180% +$43.7K ﹤0.01% 3144
2020
Q1
$0 Sell
15
-10,396
-100% ﹤0.01% 3861
2019
Q4
$205K Buy
+10,411
New +$205K 0.02% 568
2019
Q3
Sell
-1,898
Closed -$34K 4500
2019
Q2
$34K Buy
1,898
+1,858
+4,645% +$33.3K ﹤0.01% 1832
2019
Q1
$1K Buy
+40
New +$1K ﹤0.01% 3627